997 LENOX DRIVE, LAWRENCEVILLE, NJ
Financial Results, Press Release
Imunon, Inc. Registers Additional $7 Million of Common Stock Shares
Chief Scientific Officer Retirement - Khursheed Anwer Steps Down
Interim CFO Resignation - Kimberly Graper Steps Down at Imunon, Inc.
Announces Pricing of $7.0 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules
Reports Third Quarter 2025 Financial Results and Provides Business Update
Successfully Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement
Reports Second Quarter 2025 Financial Results and Provides Business Update
FY 2025
Q3
Q2
Q1
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
S-1
Notice of Exempt Offering of Securities
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence